ERIS Lifescience

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE406M01024
  • NSEID: ERIS
  • BSEID: 540596
INR
1,291.30
21 (1.65%)
BSENSE

Mar 24

BSE+NSE Vol: 1.83 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Acutaas Chemical
Granules India
Natco Pharma
ERIS Lifescience
Pfizer
Astrazeneca Phar
Piramal Pharma
Neuland Labs.
Jubilant Pharmo
OneSource Speci.
Wockhardt

Why is ERIS Lifesciences Ltd ?

1
Poor long term growth as Operating profit has grown by an annual rate 17.18% of over the last 5 years
2
Flat results in Dec 25
  • INVENTORY TURNOVER RATIO(HY) Lowest at 7.31 times
  • DEBTORS TURNOVER RATIO(HY) Lowest at 4.63 times
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is ERIS Lifescience for you?

Medium Risk, Medium Return

Absolute
Risk Adjusted
Volatility
ERIS Lifescience
-4.88%
-0.16
31.12%
Sensex
-5.02%
-0.39
12.81%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
21.09%
EBIT Growth (5y)
17.18%
EBIT to Interest (avg)
32.22
Debt to EBITDA (avg)
1.59
Net Debt to Equity (avg)
0.75
Sales to Capital Employed (avg)
0.58
Tax Ratio
22.57%
Dividend Payout Ratio
0.28%
Pledged Shares
16.92%
Institutional Holding
27.17%
ROCE (avg)
17.25%
ROE (avg)
16.76%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
40
Industry P/E
31
Price to Book Value
5.79
EV to EBIT
24.89
EV to EBITDA
18.39
EV to Capital Employed
3.74
EV to Sales
6.56
PEG Ratio
1.24
Dividend Yield
NA
ROCE (Latest)
14.24%
ROE (Latest)
13.45%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
PBT LESS OI(Q)

At Rs 162.57 cr has Grown at 44.97%

NET SALES(Q)

Highest at Rs 807.45 cr

PAT(Q)

At Rs 112.63 cr has Grown at 34.5%

-3What is not working for the Company
INVENTORY TURNOVER RATIO(HY)

Lowest at 7.31 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 4.63 times

Loading Valuation Snapshot...

Here's what is working for ERIS Lifescience

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 162.57 cr has Grown at 44.97%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Net Sales - Quarterly
Highest at Rs 807.45 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 112.63 cr has Grown at 34.5%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Here's what is not working for ERIS Lifescience

Inventory Turnover Ratio- Half Yearly
Lowest at 7.31 times and Fallen
each half year in the last five half yearly periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio- Half Yearly
Lowest at 4.63 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio